Xiaoguang Chen Selected Research

Stroke (Strokes)

7/2013	The sonic hedgehog pathway mediates brain plasticity and subsequent functional recovery after bone marrow stromal cell treatment of stroke in mice.
8/2007	Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts.
6/2006	Bone marrow stromal cells induce BMP2/4 production in oxygen-glucose-deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells.
9/2003	Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoguang Chen Research Topics

Disease

77	Neoplasms (Cancer) 01/2024 - 07/2004
13	Infections 09/2021 - 01/2013
10	Breast Neoplasms (Breast Cancer) 05/2023 - 07/2004
6	Acute Kidney Injury (Acute Renal Failure) 08/2023 - 05/2014
6	Inflammation (Inflammations) 03/2023 - 07/2010
6	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 01/2017
6	Rheumatoid Arthritis 01/2022 - 10/2011
6	Neoplasm Metastasis (Metastasis) 07/2021 - 12/2009
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 02/2010
4	Fibrosis (Cirrhosis) 03/2023 - 10/2012
4	Hypoxia (Hypoxemia) 01/2023 - 07/2012
4	Arthritis (Polyarthritis) 10/2022 - 05/2007
4	Glioma (Gliomas) 02/2022 - 01/2019
4	Dengue (Dengue Fever) 09/2021 - 01/2014
4	Virus Diseases (Viral Diseases) 09/2021 - 10/2014
4	Ischemia 12/2019 - 04/2002
4	Stroke (Strokes) 07/2013 - 09/2003
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2007 - 04/2002
3	Glomerulonephritis 04/2024 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2024 - 04/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2020
3	Bites and Stings (Sting) 05/2023 - 01/2020
3	Malaria 01/2023 - 04/2011
3	Albuminuria 08/2022 - 01/2017
3	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2022 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 01/2014
3	Experimental Arthritis 01/2019 - 05/2017
2	Prostatic Neoplasms (Prostate Cancer) 12/2024 - 12/2020
2	Colonic Neoplasms (Colon Cancer) 05/2023 - 01/2014
2	Stomach Neoplasms (Stomach Cancer) 04/2023 - 05/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2010
2	Wounds and Injuries (Trauma) 02/2022 - 01/2017
2	Chronic Renal Insufficiency 01/2022 - 01/2020
2	Flavivirus Infections 09/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2021 - 06/2019

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2007
10	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 07/2004
8	coumarinIBA 02/2022 - 02/2010
7	MicroRNAs (MicroRNA)IBA 05/2015 - 01/2013
5	EnzymesIBA 01/2024 - 01/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023 - 04/2007
5	Chlorogenic AcidIBA 01/2023 - 01/2017
5	Long Noncoding RNAIBA 08/2022 - 01/2020
5	Messenger RNA (mRNA)IBA 08/2022 - 11/2015
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2011
4	Therapeutic UsesIBA 03/2023 - 03/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2016
4	CytokinesIBA 01/2023 - 04/2011
4	LigandsIBA 09/2022 - 04/2007
4	Phosphotransferases (Kinase)IBA 01/2020 - 12/2009
4	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 07/2014
4	NitrogenIBA 01/2017 - 01/2013
4	nicousamideIBA 01/2017 - 01/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013 - 02/2010
3	Antigen-Antibody Complex (Immune Complex)IBA 04/2024 - 01/2013
3	Losartan (Cozaar)FDA LinkGeneric 04/2024 - 10/2012
3	Bovine Serum AlbuminIBA 04/2024 - 01/2013
3	Tryptophan (L-Tryptophan)FDA Link 04/2024 - 02/2020
3	Histone Deacetylase InhibitorsIBA 01/2024 - 01/2021
3	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 01/2014
3	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 05/2014
3	ProdrugsIBA 07/2023 - 01/2018
3	InterferonsIBA 01/2023 - 07/2010
3	MethyltransferasesIBA 01/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 08/2022 - 11/2015
3	AntibodiesIBA 06/2022 - 07/2014
3	Antiviral Agents (Antivirals)IBA 09/2021 - 02/2018
3	Liposomes (Liposome)IBA 07/2021 - 01/2019
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 05/2016
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2020 - 06/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 02/2010
3	AlbuminsIBA 01/2019 - 01/2013
3	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2013
2	benzamideIBA 11/2023 - 12/2022
2	CoumarinsIBA 11/2023 - 01/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023 - 07/2018
2	p38 Mitogen-Activated Protein KinasesIBA 08/2023 - 07/2010
2	Tubulin ModulatorsIBA 05/2023 - 12/2022
2	Bleomycin (Blenoxane)FDA LinkGeneric 03/2023 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Colchicine FDA LinkGeneric 12/2022 - 12/2020
2	TubulinIBA 12/2022 - 12/2020
2	AlkaloidsIBA 12/2022 - 05/2007
2	AntioxidantsIBA 10/2022 - 01/2017
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2022 - 01/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 05/2016
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 12/2019
2	GlycosidesIBA 01/2022 - 01/2012
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2021
2	AcidsIBA 01/2021 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 11/2007
2	Mannose ReceptorIBA 09/2020 - 01/2019
2	Lipocalin-2IBA 01/2020 - 01/2017

Therapy/Procedure

19	Therapeutics 12/2024 - 09/2003
7	Oral Administration 02/2022 - 01/2014
6	Immunotherapy 01/2024 - 02/2020
5	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
4	Aftercare (After-Treatment) 10/2022 - 07/2013
2	Intravenous Injections 08/2022 - 02/2022